Cargando…
Mass cytometry analysis reveals attrition of naïve and anergized self-reactive non-malignant B cells in chronic lymphocytic leukemia patients
Chronic Lymphocytic Leukemia (CLL) is characterized by the progressive accumulation of monoclonal mature B lymphocytes. Autoimmune complications are common in CLL occurring in up to a quarter of all patients during the course of the illness. Etiology of autoimmunity in CLL is unknown but it is widel...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661965/ https://www.ncbi.nlm.nih.gov/pubmed/36387187 http://dx.doi.org/10.3389/fonc.2022.1020740 |
_version_ | 1784830580839415808 |
---|---|
author | Andrieu, Thibault Mondière, Paul Jouve, Pierre-Emmanuel Dussurgey, Sébastien Malassigné, Victor Servanton, Hugo Baseggio, Lucille Davi, Frédéric Michallet, Anne-Sophie Defrance, Thierry |
author_facet | Andrieu, Thibault Mondière, Paul Jouve, Pierre-Emmanuel Dussurgey, Sébastien Malassigné, Victor Servanton, Hugo Baseggio, Lucille Davi, Frédéric Michallet, Anne-Sophie Defrance, Thierry |
author_sort | Andrieu, Thibault |
collection | PubMed |
description | Chronic Lymphocytic Leukemia (CLL) is characterized by the progressive accumulation of monoclonal mature B lymphocytes. Autoimmune complications are common in CLL occurring in up to a quarter of all patients during the course of the illness. Etiology of autoimmunity in CLL is unknown but it is widely admitted that the pathogenic auto-Abs do not originate from the tumoral clone but from the non-malignant B cell pool. This indicates that the developmental scheme of non-malignant B cells could also be perturbed in CLL patients. To address this question, we have designed a B cell-centered antibody panel and used time-of-flight mass cytometry to compare the residual non-malignant B cell pool of CLL patients with the peripheral B cell pool of age-matched healthy donors. We show that the non-malignant B cell compartment of the patients is characterized by profound attrition of naïve B cells and of a population of anergized autoreactive B cells, suggesting impaired B cell lymphopoeisis as well as perturbations of the B cell tolerance checkpoints. |
format | Online Article Text |
id | pubmed-9661965 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96619652022-11-15 Mass cytometry analysis reveals attrition of naïve and anergized self-reactive non-malignant B cells in chronic lymphocytic leukemia patients Andrieu, Thibault Mondière, Paul Jouve, Pierre-Emmanuel Dussurgey, Sébastien Malassigné, Victor Servanton, Hugo Baseggio, Lucille Davi, Frédéric Michallet, Anne-Sophie Defrance, Thierry Front Oncol Oncology Chronic Lymphocytic Leukemia (CLL) is characterized by the progressive accumulation of monoclonal mature B lymphocytes. Autoimmune complications are common in CLL occurring in up to a quarter of all patients during the course of the illness. Etiology of autoimmunity in CLL is unknown but it is widely admitted that the pathogenic auto-Abs do not originate from the tumoral clone but from the non-malignant B cell pool. This indicates that the developmental scheme of non-malignant B cells could also be perturbed in CLL patients. To address this question, we have designed a B cell-centered antibody panel and used time-of-flight mass cytometry to compare the residual non-malignant B cell pool of CLL patients with the peripheral B cell pool of age-matched healthy donors. We show that the non-malignant B cell compartment of the patients is characterized by profound attrition of naïve B cells and of a population of anergized autoreactive B cells, suggesting impaired B cell lymphopoeisis as well as perturbations of the B cell tolerance checkpoints. Frontiers Media S.A. 2022-10-31 /pmc/articles/PMC9661965/ /pubmed/36387187 http://dx.doi.org/10.3389/fonc.2022.1020740 Text en Copyright © 2022 Andrieu, Mondière, Jouve, Dussurgey, Malassigné, Servanton, Baseggio, Davi, Michallet and Defrance https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Andrieu, Thibault Mondière, Paul Jouve, Pierre-Emmanuel Dussurgey, Sébastien Malassigné, Victor Servanton, Hugo Baseggio, Lucille Davi, Frédéric Michallet, Anne-Sophie Defrance, Thierry Mass cytometry analysis reveals attrition of naïve and anergized self-reactive non-malignant B cells in chronic lymphocytic leukemia patients |
title | Mass cytometry analysis reveals attrition of naïve and anergized self-reactive non-malignant B cells in chronic lymphocytic leukemia patients |
title_full | Mass cytometry analysis reveals attrition of naïve and anergized self-reactive non-malignant B cells in chronic lymphocytic leukemia patients |
title_fullStr | Mass cytometry analysis reveals attrition of naïve and anergized self-reactive non-malignant B cells in chronic lymphocytic leukemia patients |
title_full_unstemmed | Mass cytometry analysis reveals attrition of naïve and anergized self-reactive non-malignant B cells in chronic lymphocytic leukemia patients |
title_short | Mass cytometry analysis reveals attrition of naïve and anergized self-reactive non-malignant B cells in chronic lymphocytic leukemia patients |
title_sort | mass cytometry analysis reveals attrition of naïve and anergized self-reactive non-malignant b cells in chronic lymphocytic leukemia patients |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661965/ https://www.ncbi.nlm.nih.gov/pubmed/36387187 http://dx.doi.org/10.3389/fonc.2022.1020740 |
work_keys_str_mv | AT andrieuthibault masscytometryanalysisrevealsattritionofnaiveandanergizedselfreactivenonmalignantbcellsinchroniclymphocyticleukemiapatients AT mondierepaul masscytometryanalysisrevealsattritionofnaiveandanergizedselfreactivenonmalignantbcellsinchroniclymphocyticleukemiapatients AT jouvepierreemmanuel masscytometryanalysisrevealsattritionofnaiveandanergizedselfreactivenonmalignantbcellsinchroniclymphocyticleukemiapatients AT dussurgeysebastien masscytometryanalysisrevealsattritionofnaiveandanergizedselfreactivenonmalignantbcellsinchroniclymphocyticleukemiapatients AT malassignevictor masscytometryanalysisrevealsattritionofnaiveandanergizedselfreactivenonmalignantbcellsinchroniclymphocyticleukemiapatients AT servantonhugo masscytometryanalysisrevealsattritionofnaiveandanergizedselfreactivenonmalignantbcellsinchroniclymphocyticleukemiapatients AT baseggiolucille masscytometryanalysisrevealsattritionofnaiveandanergizedselfreactivenonmalignantbcellsinchroniclymphocyticleukemiapatients AT davifrederic masscytometryanalysisrevealsattritionofnaiveandanergizedselfreactivenonmalignantbcellsinchroniclymphocyticleukemiapatients AT michalletannesophie masscytometryanalysisrevealsattritionofnaiveandanergizedselfreactivenonmalignantbcellsinchroniclymphocyticleukemiapatients AT defrancethierry masscytometryanalysisrevealsattritionofnaiveandanergizedselfreactivenonmalignantbcellsinchroniclymphocyticleukemiapatients |